Radioactive Gas Handling and Effluent Control

Introduction

A vial of radioactive liquid stays where you put it; a radioactive gas does not. The moment a noble gas such as xenon-133 escapes its delivery circuit, it mixes with room air, can be breathed, and drifts out through the ventilation system. That single difference reshapes the entire safety program: instead of wiping a benchtop, the health physicist is managing room pressure, air changes, traps, air monitoring, and what leaves the building through the exhaust stack.¹⁵

Radioactive gases and aerosols have a long history in ventilation imaging — xenon-133 for lung ventilation studies, and technetium-99m aerosols such as Technegas and DTPA as particulate alternatives. Each is safe when handled in a system designed for it, and each fails in a characteristic way when it is not. Because a noble gas delivers dose by external submersion rather than by internal deposition, its controls and its regulatory limits look different from anything else in the hot lab.⁶

This article explains how radioactive gases and aerosols behave, how submersion dose and effluent limits work, how engineered controls contain the hazard, and how the program aligns with the NRC and Agreement State framework. DRPS provides this analysis as part of its radiation safety officer consulting and PET/CT and nuclear medicine physics services across Florida, Maryland, Virginia, Washington DC, California, and Nevada.

Topic Explanation

Gases, aerosols, and why the distinction matters

Two families of airborne agents are used in ventilation imaging, and they must be handled differently:

• Radioactive gases, principally xenon-133, are true gases (xenon is a noble gas). They cannot be filtered like particulates, they fill whatever volume they can reach, and their dominant hazard is external whole-body dose from submersion in a contaminated air cloud rather than from retention in the body.²
• Radioactive aerosols, principally technetium-99m preparations such as Technegas (ultrafine labeled carbon particles) and Tc-99m DTPA droplets, are particulates. They can deposit on surfaces and skin, so they behave like removable contamination, but they are delivered in closed systems and do not diffuse through a room the way a gas does.

The physical data drive the controls. Xenon-133 decays by beta emission to stable cesium-133 with a physical half-life of about 5.24 days, emitting a principal 81 keV gamma photon (with lower-energy X-rays around 31–35 keV).²⁶ Technetium-99m has a 6-hour half-life and a 140 keV photon, so a Tc-99m aerosol spill decays away quickly and is managed as surface contamination. For the imaging side of these studies, see our companion article on V/Q lung scintigraphy physics.

Submersion: a different dose pathway

For most unsealed radionuclides, the concern is intake — inhalation or ingestion leading to committed internal dose. A noble gas is chemically inert and is not appreciably retained, so the relevant pathway is external immersion: standing inside a cloud of gas irradiates the whole body from all directions. This is why the xenon-133 air limit in the regulations is explicitly a submersion value, and why the protective strategy is to keep the gas out of occupied air and move it quickly to a controlled exhaust, rather than to rely on respiratory protection alone.²³

Key Technical Principles

The regulatory concentrations

Two 10 CFR Part 20 Appendix B numbers frame the program. The occupational Derived Air Concentration (DAC) for xenon-133 is:

A DAC is the concentration that, breathed (or here, submerged in) for 2,000 working hours a year, delivers the occupational dose limit. The effluent concentrations in Appendix B Table 2 are far lower: by design they correspond to a public dose of 50 mrem (0.5 mSv) per year of continuous exposure, consistent with the public-dose framework of 10 CFR 20.1301.²³ The occupational whole-body limit itself is a total effective dose equivalent of 5 rem (50 mSv) per year, and the public limit is 100 mrem (1 mSv) per year, with no more than 2 mrem in any one hour in an unrestricted area.³

Air changes dominate room clearance

When gas escapes into a room, its concentration falls through two processes: physical decay and ventilation removal. Both are first-order, so they add:

The physical decay constant for xenon-133 is small:

The ventilation removal constant equals the room air-change rate. A room with a modest 6 air changes per hour (ACH) gives (\lambda_{\text{vent}} = 6\ \text{h}^{-1}), which is more than a thousand times larger than the decay term. Ventilation, not decay, clears a xenon spill.

A worked spill-clearance example

Suppose a delivery-circuit leak raises the room concentration to (C_0 = 5 \times 10^{-4}\ \mu\text{Ci/mL}) — five times the occupational DAC — and the room provides 6 ACH. Because ventilation dominates, use (\lambda_{\text{eff}} \approx \lambda_{\text{vent}} = 6\ \text{h}^{-1}). The time to fall below the DAC of (1 \times 10^{-4}\ \mu\text{Ci/mL}) is:

So a five-fold-over-DAC release in a well-ventilated room clears below the occupational limit in roughly a quarter of an hour — provided the room is at negative pressure so the gas leaves through the exhaust rather than the corridor. Posting this clearance time and keeping staff out until it elapses is a standard spill procedure. Doubling the air-change rate roughly halves the time; a room with poor ventilation extends it dramatically, which is exactly why room design is a safety control and not just a comfort feature. This complements the general framework in our airborne radioactivity area and ventilation controls article.

Clinical Impact

The room is the primary safety device

For gas work, engineered controls do most of the protecting. The design goals are straightforward but exacting:

• Negative pressure in the imaging room relative to adjacent spaces, so leaked gas flows inward and out a dedicated exhaust, never into corridors or waiting areas.
• Adequate air changes to clear spills quickly, verified rather than assumed.
• Closed delivery — a rebreather spirometer circuit or shielded dispenser — that keeps the gas in the circuit during administration.
• Trapping or controlled exhaust for exhaled and excess gas: activated-charcoal xenon traps adsorb the gas for decay, or a monitored roof exhaust releases it at concentrations below Appendix B Table 2 limits.

When these controls are correct, staff dose is low and effluent is compliant almost automatically. When they are wrong — a room that has lost negative pressure, a saturated or bypassed trap, an exhaust that recirculates — the same gas becomes a whole-department problem. This is why gas rooms belong in the same design conversation as the nuclear medicine hot lab.

Effluent: what leaves the building

Because a noble gas ultimately leaves through the exhaust, the program must show that what reaches the environment is within limits. That means knowing the release point, the dilution, and the concentration at the point of release relative to the Appendix B Table 2 effluent value, and keeping records that demonstrate compliance. Facilities that release xenon to the atmosphere through a stack must be able to defend that release the same way they defend airborne effluent and public dose for any other pathway.

Aerosols: a contamination problem, not a submersion problem

Technetium aerosols shift the hazard back to familiar ground. A Technegas or DTPA leak deposits activity on surfaces, the delivery device, and potentially the technologist's hands and clothing, so it is surveyed, decontaminated, and allowed to decay like any Tc-99m spill. The short half-life is a genuine advantage: a spill that would be a multi-day concern for a long-lived nuclide is largely gone within a shift. The trade-off is that particulate control (closed nebulizers, spill trays, contamination surveys) replaces the gas-tight containment and exhaust logic that xenon demands.

Practical Tips

1. Verify the room, not just the equipment

• Confirm and periodically re-verify negative pressure and air-change rate; a smoke test or pressure monitor is worth more than a design drawing.
• Ensure the exhaust discharges where it cannot be drawn back into intakes or occupied areas.

2. Keep the gas in a closed circuit

• Use rebreather spirometer delivery and inspect the circuit, valves, and connections for leaks before each study.
• Route exhaled and excess gas to a charcoal trap or monitored exhaust; track trap loading and replace or regenerate before breakthrough.

3. Monitor the air and post clearance times

• Provide air monitoring appropriate to the workload to identify airborne radioactivity areas and demonstrate compliance; see ALI and DAC internal dose limits for how these concentrations tie to dose.
• Pre-compute and post spill-clearance times for the room so staff know how long to stay out after a release.

4. Have a gas-specific spill procedure

• For a gas release: evacuate, leave the room at negative pressure with the exhaust running, and re-enter only after the posted clearance time.
• For an aerosol spill: contain, survey, decontaminate, and let the short-lived activity decay, following the same logic as radioactive material spill response.

5. Train for the hazard that actually applies

• Teach staff that xenon is a submersion (external) hazard managed by leaving the cloud, while technetium aerosols are a contamination hazard managed by surveying and cleaning. Confusing the two leads to the wrong reflex in an incident.

Common pitfalls to avoid

• Treating a gas like a liquid. Wiping surfaces does nothing for a noble gas; ventilation and containment do the work.
• Assuming the trap is fine. A saturated or channeled charcoal trap can pass gas straight through; loading must be tracked.
• Ignoring room pressure drift. A gas room that has silently lost negative pressure sends activity into corridors.
• Skipping effluent records. Even a compliant release must be documentable for inspection.
• Applying the wrong incident reflex. Surveying for surface contamination after a xenon release wastes time while the real control — leaving until the room clears — is what matters.

Regulatory Considerations

A radioactive-gas program must satisfy the same 10 CFR Part 20 dose and effluent limits as any other licensed use, plus the medical-use conditions of 10 CFR Part 35, and it must document that its engineered controls actually work. Key frameworks include:

• 10 CFR Part 20 — Standards for Protection Against Radiation, setting the occupational (5 rem/yr TEDE) and public (100 mrem/yr; 2 mrem in any hour in unrestricted areas) dose limits, airborne-radioactivity-area definitions, and effluent requirements.³
• 10 CFR Part 20 Appendix B — the table of DAC and effluent concentrations, including the xenon-133 submersion DAC of 1 × 10⁻⁴ µCi/mL and the much lower Table 2 effluent values.²
• 10 CFR Part 35 — Medical Use of Byproduct Material, governing authorized use, safety precautions, surveys, and the RSO's responsibilities for these radiopharmaceuticals.⁴
• NRC NUREG-1556, Volume 9 — program-specific licensing guidance for medical use, including expectations for facility design, ventilation, air monitoring, and procedures for radioactive gases and aerosols.⁵
• IAEA SSG-46 and ICRP Publication 107 — international safety guidance for medical uses of ionizing radiation and the authoritative nuclear decay data used for these calculations.⁶⁷

Agreement States administer their own equivalent programs. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States licensing medical use under their own radiation-control rules, while Washington, DC and Delaware are regulated directly by the NRC for radioactive material. A facility must confirm which authority issues its license and sets its air-monitoring and effluent requirements. For a state-specific example, see Florida radiation safety requirements for imaging centers, and connect the gas program to radioactive material license support when starting, moving, or changing agents.

Frequently Asked Questions (FAQs)

Why are radioactive gases treated differently from other radiopharmaceuticals?

A radioactive gas or aerosol is not confined to a vial or a patient's body. Once released it mixes with room air, can be inhaled, and leaves through the ventilation system. For a noble gas such as xenon-133 the main hazard is external whole-body dose from submersion in a contaminated air cloud, so controls focus on containment, room ventilation, air monitoring, and effluent release rather than only on surface contamination.

What is the main hazard from xenon-133?

Xenon-133 is a noble gas, so it is not metabolized or retained in the body in a meaningful way. Its dominant occupational hazard is external dose from immersion in a cloud of the gas, which is why its regulatory limit is expressed as a submersion Derived Air Concentration. Its principal photon is an 81 keV gamma ray, and it decays by beta emission with a physical half-life of about 5.24 days.

What is the occupational air concentration limit for xenon-133?

Under 10 CFR Part 20 Appendix B, the occupational Derived Air Concentration for xenon-133 is 1 × 10⁻⁴ microcuries per milliliter, footnoted as a submersion value because the dose is delivered externally. Effluent released to unrestricted areas is held to much lower Table 2 concentrations, which correspond to a public dose of 50 millirem per year of continuous exposure.

How do negative-pressure rooms and traps control the gas?

Ventilation studies are performed in rooms held at negative pressure relative to adjacent areas so that any leaked gas flows inward and out through a dedicated exhaust rather than into corridors. Closed delivery systems and rebreather spirometers keep the gas in the circuit, and exhaled or excess gas is routed to activated-charcoal traps or a controlled roof exhaust for monitored release.

Are technetium aerosols like Technegas safer than xenon gas?

They pose a different, generally more containable hazard. Technetium-99m aerosols such as Technegas or DTPA are particulates, not noble gases, so they can deposit on surfaces and cause removable contamination, but they are delivered in a closed system and do not fill a room the way a gas does. Technetium-99m has a 6-hour half-life and a 140 keV photon, and spills are managed as surface contamination.

What air monitoring is required?

Facilities must evaluate airborne concentrations to determine whether an area is an airborne radioactivity area, to demonstrate that occupational intakes and submersion doses are within limits, and to show that effluent releases meet 10 CFR Part 20 limits. This can include continuous or periodic air sampling, room air-change verification, exhaust monitoring, and documented spill-clearance calculations.

When should a facility get a physics or RSO review of its gas program?

Request a review before starting or relocating ventilation imaging, when changing agents, when modifying room ventilation or exhaust, after a spill or air-monitor alarm, or during license renewal. The review should confirm room pressure and air changes, trap and exhaust performance, air-monitoring adequacy, effluent compliance, and spill procedures against the license and applicable rules.

Key Takeaways

• A gas is not a liquid. Once released, a noble gas fills the air and leaves through the ventilation system, so containment and exhaust — not surface wiping — are the controls.
• Xenon-133 is a submersion hazard. Its dominant dose pathway is external immersion, which is why its 10 CFR 20 limit is a submersion DAC of 1 × 10⁻⁴ µCi/mL.
• Ventilation clears the room, not decay. With a physical half-life of 5.24 days, xenon relies on air changes; a well-ventilated room clears a modest spill in minutes.
• The room is the primary safety device. Negative pressure, verified air changes, closed delivery, and charcoal traps or monitored exhaust do most of the protecting.
• Effluent must be documented. Releases to unrestricted areas must meet the much lower Appendix B Table 2 concentrations and be defensible at inspection.
• Aerosols shift the hazard. Technetium Technegas and DTPA are contamination problems with a short half-life, managed by closed delivery, surveys, and decay.

Conclusion

Radioactive gas and aerosol handling is a case study in matching the control to the physics. A noble gas cannot be filtered or wiped up; it is managed by keeping it in a closed circuit, holding the room at negative pressure, trapping or venting the exhaust, monitoring the air, and documenting what leaves the building. A technetium aerosol reverts to the familiar logic of contamination control and short-lived decay. Getting the two straight — and building rooms and procedures around the correct hazard — is what keeps staff dose low, effluent compliant, and the program defensible.

The health physicist's job here is less about a survey meter on a benchtop and more about the engineering of air: pressure, changes, traps, and exhaust. When those systems are designed, verified, and understood by the staff who use them, ventilation imaging is a low-risk service. When they are assumed rather than confirmed, a single leak becomes a department-wide event. The difference is a program that treats the room and its ventilation as the primary safety device it truly is.

How DRPS Can Help

Diagnostic Radiation Physics Services helps nuclear medicine facilities design and defend their radioactive-gas and aerosol programs. This includes ventilation-room and exhaust review, air-monitoring and effluent-compliance assessment, spill-clearance calculations, procedure and training support, radiation safety officer consulting, radioactive material license support, and radiation safety training aligned with NRC and Agreement State requirements.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A gas program is safe when the safe way is also the easy way — closed circuits, a room that protects itself, and staff who know which hazard they are actually managing.

Related Resources

• Airborne radioactivity area and ventilation controls
• Airborne effluent and public dose
• ALI and DAC internal dose limits
• Radioactive material spill response
• Nuclear medicine hot lab design
• V/Q lung scintigraphy physics
• Radiation Safety Officer consulting
• Radioactive material license support

References

1. U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov
2. U.S. Nuclear Regulatory Commission. 10 CFR Part 20, Appendix B — Annual Limits on Intake (ALIs) and Derived Air Concentrations (DACs): Xenon-133. nrc.gov
3. U.S. Nuclear Regulatory Commission. 10 CFR 20.1201 and 20.1301: Occupational and public dose limits. ecfr.gov
4. U.S. Nuclear Regulatory Commission. 10 CFR Part 35: Medical Use of Byproduct Material. ecfr.gov
5. U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 9, Revision 3: Consolidated Guidance About Materials Licenses — Program-Specific Guidance About Medical Use Licenses. nrc.gov
6. International Atomic Energy Agency. Radiation Protection and Safety in Medical Uses of Ionizing Radiation (IAEA Safety Standards Series No. SSG-46). Vienna: IAEA; 2018. iaea.org
7. International Commission on Radiological Protection. ICRP Publication 107: Nuclear Decay Data for Dosimetric Calculations. Ann ICRP. 2008;38(3). icrp.org
8. U.S. Food and Drug Administration. Xenon Xe 133 Gas — prescribing information (physical and radiation characteristics). accessdata.fda.gov
9. Society of Nuclear Medicine and Molecular Imaging. Procedure Standard/Practice Guideline for Lung Scintigraphy (ventilation–perfusion imaging). snmmi.org